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	ABSTRACT	
	
OBJECTIVE:		to	summarize	major	recent	studies	in	the	field.	
	
INTERSALT:		sodium	intake	correlates	with	the	rise	in	blood	pressure	with	age,	but	not	with	the	
prevalence	of	hypertension.		The	population	study	identified	a	minimal	impact	of	sodium	intake	
on	blood	pressure	(0.9	mm	Hg	/10	mmol	difference	in	salt	intake).			
	
DASH:		this	diet	induced	significant	reductions	in	blood	pressure	when	compared	to	the	control	
diet.		Further	decreases	were	observed	with	DASH	and	a	50	mmol/day	sodium	intake.			
	
VANGUARD:		blood	pressure	was	inversely	related	to	urinary	potassium,	calcium	and	
magnesium	but	not	to	sodium	excretion.			
	
TONE:		cardiovascular	events	were	highest	in	the	usual	care	group	(83%)	and	lowest	in	the	
sodium	reduction	plus	weight	loss	group	(56%).		
	
META-ANALYSIS:		a	systematic	review	of	eleven	long	term	controlled	randomized	trials	
reported	a	small	decrease	(1.1	mm	Hg)	in	median	systolic	but	not	diastolic	blood	pressure	with	
a	reduced	dietary	sodium	intake.	
	
CONCLUSIONS:		1)	Sodium	restriction	in	hypertensive	patients	reduces	blood	pressure.		2)	The	
long	term	impact	of	reduced	salt	intake	on	blood	pressure,	mortality,	and	morbidity	remains	to	
be	defined.			
	
		
	
	
Introduction	
	
Systemic	arterial	pressure	is	regulated	by	complex	interactive	systems,	including	the	
circulatory	volume,	vascular	resistance	vessels,	central	nervous	system,	kidneys,	and	endocrine	
components.		The	relationship	between	salt	consumption	and	blood	pressure	continues	to	
generate	considerable	discussion	and	debate.		Kempner	used	a	very	low-salt	rice	diet	(0.6	g	
sodium,	5	g	fat,	20	g	protein	per	day)	to	reduce	blood	pressure	in	patients	with	malignant	
hypertension	and	renal	failure	(1).		Guyton	showed	that	a	rise	in	blood	pressure	caused	a	
pressure	sodium	diuresis	that	reduced	vascular	volume	and	lowered	blood	pressure.		He	
concluded	that	renal	compensation	is	reduced	in	essential	hypertension	(2).			An	anatomical	
counterpart	to	this	reduced	compensation	to	dietary	salt	intake	is	the	decreased	nephron	
number	reported	in	patients	with	essential	hypertension	(3).		Dahl	correlated	the	prevalence	of	
HTN	in	five	geographically	distinct	populations	with	their	average	daily	salt	intake	and	published	
his	results	in	a	monograph	(4).			He	proposed	that	the	prevalence	of	hypertension	rises	linearly	
with	salt	consumption	between	4	and	26	grams	per	day.		Many	population	studies	have	
followed,	but	results	have	often	been	conflicting.				
	
NHLBI	INTERSALT	STUDY		
This	is	a	multicenter	study	of	10,079	patients	in	52	centers	around	the	world.		Sodium	
excretion	ranged	from	0.12	to	242	mmol/24	hours	(5).		Subjects	in	the	four	remote	areas	
(Yanomamo	and	Xingu	in	Brazil,	Papua-New	Guinea,	and	Kenya)	had	the	lowest	sodium	
excretion	and	were	all	within	the	lowest	quintile	(6).		Systolic	blood	pressure	showed	a	minimal	
or	no	increase	by	age	55.		Diastolic	blood	pressure	had	a	discrete	increase	only	in	the	Kenya	
cohort.		The	prevalence	of	hypertension	was	very	low	(Yanomamo	0%,	Xingu	1%,	Papua	New	
Guinea	1%,	and	Kenya	3%)	(7).		Across	the	other	48	centers,	sodium	intake	was	significantly	
related	to	a	rise	in	blood	pressure	with	age.		No	correlation	was	found	between	sodium	and	
median	blood	pressure	or	the	prevalence	of	hypertension.			More	important,	no	correlation	was	
found	between	sodium	excretion	and	blood	pressure	in	the	cross	sectional	population	study	
unless	the	four	outliers	(remote	population	subgroup)	were	included	in	the	analysis.		The	
relationship	between	blood	pressure	and	age	was	stronger	in	populations	with	high	rather	than	
low	salt	intake.		However,	the	increase	was	rather	small	(0.9	mm	Hg	for	each	10	mmol	increase	
in	salt	intake).				
	
Population	studies,	such	as	INTERSALT,	have	built-in	limitations.		There	are	significant	
ecological	and	cultural	differences	among	population	centers.		Spot	blood	pressure	and	sodium	
excretion	values	are	extremely	variable	between	centers	and	within	individuals.		In	order	to	
adjust	for	multiple	confounders	and	to	correct	for	dilutional	regression,	a	reanalysis	of	the	
entire	data	was	done	in	1996	(8).		These	authors	reported	a	strong	association	between	urinary	
sodium	and	systolic	pressure	in	both	individuals	and	population	centers.		Others	felt	that	such	
manipulation	significantly	undermined	the	credibility	of	the	INTERSALT	study	(9,10).		An	
alternative	explanation	is	that	there	is	a	threshold	for	the	effect	of	sodium	intake	on	blood	
pressure	at	around	100	mmol	per	day	(11).			
	
Differences	in	response	to	salt	intake	may	also	be	related	to	time	exposure	and	varying	salt	
sensitivity	(12).		A	meta-analysis	study	of	mostly	crossover	design	noted	that	trials	lasting	up	to	
four	weeks	reduced	blood	pressure	less	than	those	carried	out	for	five	weeks	or	longer	(13).		A	
50	mmol	reduction	in	daily	sodium	intake	lowered	systolic	blood	pressure	by	5-7	mm	Hg	and	
diastolic	values	by	1.5-2.5	mm	Hg.		Based	on	these	results	Law	et	al.	argued	for	a	universal	
dietary	salt	reduction.		A	second	large	meta-analysis	reported	somewhat	different	conclusions	
(14).		In	this	study	a	reduced	dietary	sodium	intake	was	associated	with	a	3.9	mm	Hg	decrease	
in	systolic	and	a	1.9	mm	Hg	reduction	in	diastolic	blood	pressure	in	hypertensive	subjects.		In	
normotensive	individuals,	lowering	dietary	sodium	intake	decreased	systolic	and	diastolic	blood	
pressure	only	by	1.2	mm	Hg	and	0.26	mm	Hg	respectively.		The	authors	concluded	there	was	no	
supportive	evidence	for	a	general	recommendation	to	reduce	sodium	intake.		They	did	suggest	
a	reduced	sodium	intake	as	a	supplementary	treatment	of	hypertension.		
	
	
DIETARY	APPROACHES	TO	STOP	HYPERTENSION	TRIAL	(DASH)	
	
This	is	the	most	comprehensive	study	of	diet	intervention	to	date	(15,16).		In	DASH	I,	
adults	with	blood	pressure	<160/80-95	mm	Hg	were	randomized	to	an	average		American	diet	
(control),	a	diet	rich	in	fruits	and	vegetables,	or	a	combination	diet	(DASH)	rich	in	fruits	and	
vegetables,	with	a	low	content	of	saturated	and	total	fats.		Sodium	intake	was	maintained	
constant	at	3	grams	per	day.		The	DASH	diet	reduced	systolic	and	diastolic	blood	pressure	by	5.5	
and	3.0	mm	Hg	respectively.		Hypertensive	patients	had	greater	falls	in	blood	pressure	when	
compared	to	normotensive	subjects	(11.4	and	5.5	versus	3.5	and	2.1	mm	Hg	for	systolic	and	
diastolic	blood	pressure	respectively).			DASH	II	addressed	the	added	impact	of	a	low	sodium	
intake.		Blood	pressure	progressively	decreased	in	both	the	control	and	DASH	groups	as	dietary	
sodium	was	lowered	from	150	to	50	mmol/day.		The	changes	were	more	pronounced	with	the	
DASH	diet.	
	
Subset	analysis	of	DASH-I	identified	greater	systolic	blood	pressure	reductions	in	
hypertensive	than	in	normotensive	(11.4	and	3.4	mm	Hg	respectively)	subjects	(17).		African	
Americans	had	greater	decreases	than	whites	(6.8	and	3.0	mm	Hg	respectively).		Subjects	older	
than	age	45	had	larger	reductions	in	blood	pressure	(7.0/3.8	mm	Hg)	when	compared	to	
younger	ones	(3.7/1.5	mm	Hg)	(18).		This	suggests	that	increased	sodium	sensitivity	may	be	
limited	to	the	older	non	hypertensive	population.			
	
Subjects	assigned	to	the	DASH	diet	showed	significantly	greater	decreases	in	
homocysteine	levels	than	those	on	the	control	diet.		This	change	was	significantly	and	inversely	
related	to	serum	folate	levels	but	not	vitamin	B6	or	B12	(19).		Relative	to	the	control	diet,	the	
DASH	cohort	significantly	lowered	their	total	(-13.7	mg/dL),	LDH	(-10.7	mg/dL)	and	HDL	(-3.7	
mg/dL)	cholesterol	(20).				
	
Results	from	clinical	trials	do	not	always	translate	into	clinical	practice	because	of	
different	population	characteristics	and	levels	of	adherence	to	the	treatment	protocols.		The	
PREMIER	study	evaluated	810	individuals	randomized	to	three			groups	(advice	only,	established	
intervention,	and	established	+	DASH	intervention)	(21).		The	prevalence	of	hypertension	
decreased	similarly	in	both	intervention	groups.		This	was	attributed	to	a	lower	adherence	rate	
to	the	DASH	guidelines	or	to	the	sub-additive	nature	of	intervention	effects	on	blood	pressure.		
Folsom	et	al.	have	published	a	provocative	study	using	individuals	enrolled	in	the	Iowa	
Women’s	Health	Study	(IWHS)	(22).		Their	primary	aim	was	to	assess	if	a	greater	concordance	
to	DASH	guidelines	was	associated	with	a	reduced	incidence	of	hypertension	and	cardiovascular	
mortality	in	initially	non-hypertensive	older	women.		In	univariate	analysis	a	trend	was	found	
for	a	decreasing	incidence	of	hypertension	and	cardiovascular	death	as	concordance	with	DASH	
guidelines	increased.		However,	after	adjusting	for	other	risk	factors	this	relationship	was	lost.		
The	authors	concluded	that	a	very	high	concordance,	as	achieved	in	the	DASH	trials,	may	be	
needed	for	full	benefit.		Alternatively	DASH	may	not	be	as	effective	in	older	Caucasian	and	
initially	normotensive	women.			
	
	
VANGUARD	STUDY	
	
The	VANGUARD	trial	was	designed	to	evaluate	the	impact	of	a	comprehensive	nutritional	
program	on	blood	pressure	and	to	better	define	physiologic	mechanisms	underlying	the	
antihypertensive	effects	of	such	therapies	(23).		The	study	diet	conformed	to	the	RDA	standards	
specified	by	the	National	Academy	of	Sciences,	American	Diabetes	Association,	American	Heart	
Association,	and	others	to	provide	optimal	levels	of	macro-	and	micronutrients	recommended	for	
overall	cardiovascular	risk	reduction	(24).		Subjects	were	assigned	to	a	prepared	(CCNW)	or	a	self-
selected		(SSD)	meal	plan.			
	
Reductions	in	blood	pressure	where	higher	with	CCNW	than	SSD	meals	for	systolic	(-
6.2±0.1	vs.	-4.2±0.8	mm	Hg)	and	diastolic	(-6.2±0.1	vs.	-4.2±0.8	mm	H)	blood	pressures.		Neither	
basal	blood	pressure	nor	its	change	was	related	to	absolute	or	diet-induced	changes	in	urinary	
sodium	excretion.		However,	diastolic	blood	pressure	was	significantly	and	inversely	related	to	
basal	urinary	potassium	excretion	(P	<	0.001).		In	addition,	the	greater	the	rise	in	urinary	and	
serum	potassium,	the	greater	the	fall	in	systolic	and	diastolic	blood	pressure	(P	<	0.002).		Basal	
systolic	blood	pressure	was	also	directly	related	to	urinary	calcium	excretion	(P	<	0.	0018),	
specially	in	hyperlipidemic	subjects.		Urinary	calcium,	when	considered	in	relation	to	urinary	
sodium	(UCa/UNa),	predicted	diet-induced	changes	in	both	systolic	(P	<	0.001)	and	diastolic	(P	<	
0.021)	blood	pressure.		Diet	induced	changes	in	blood	pressure	were	also	related	to	changes	in	
magnesium	excretion	(P	<	0.05).			
	
The	authors	emphasize	the	importance	of	other	minerals,	namely	calcium,	magnesium	
and	phosphorus	in	the	pathogenesis	of	hypertension.		This	is	in	agreement	with	other	studies	
which	link	the	blood	pressure	response	to	calcium	with	sodium	excretion.		They	postulate	a	
lowered	Ca/Na	ratio	(deficient	calcium	or	excess	salt)	as	a	predisposing	to	higher	blood	
pressure	in	salt-sensitive	persons,	which	is	reversed	by	restricting	sodium	or	increasing	calcium.		
They	use	these	arguments	to	support	the	ionic	hypothesis	of	cardiovascular	and	metabolic	
disease.	The	appeal	of	this	concept	is	that	it	fits	well	the	close	relationship	between	
hypertension,	obesity,	insulin	resistance,	and	type-2	diabetes.			
	
	
TRIAL	OF	NONPHARMACOLOGIC	INTERVENTIONS	IN	THE	ELDERLY	(TONE)	
	
The	TONE	study	evaluated	the	efficacy	of	sodium	restriction	and	weight	reduction	on	
cardiovascular	disease	endpoints	at	30	months	in	older	patients	with	hypertension	(25).		The	
rate	of	cardiovascular	events	was	83%	in	the	usual	care	group,	60%	in	the	low	sodium	intake	
cohort,	62%	in	the	weight	reduction	arm,	and	56%	in	the	combined	sodium	and	weight	
reduction	group.		The	authors	concluded	that	low	sodium	intake	and	weight	loss	are	effective	
and	safe	therapies	capable	of	reducing	cardiovascular	events	in	elderly	hypertensive	patients.			
	
	
IMPACT	OF	SODIUM	RESTRICTION	ON	BLOOD	PRESSURE	–	SYSTEMATIC	REVIEW	
	
As	noted	earlier,	large	systematic	reviews	on	the	effect	of	sodium	restriction	on	blood	
pressure	have	reported	conflicting	results	(13,14).		A	recent	meta-analysis	evaluated	eleven	
long-term	randomized	controlled	trials	with	3,491	participants	(26).		It	was	not	possible	to	
assess	the	impact	on	quality	of	life,	mortality,	or	cardiovascular	events	as	the	number	of	
occurrences	were	minimal.		A	mean	decrease	of	1.1	mm	Hg	in	systolic	blood	pressure	was	
noted	(P	<	0.002).		No	effect	was	observed	in	diastolic	blood	pressure.		The	authors	concluded	
that	intense	interventions	(likely	unsuited	to	primary	care	or	population	prevention	programs)	
produce	uncertain	effects	on	mortality	and	cardiovascular	events	while	attaining	only	small	
reductions	in	blood	pressure.			
	
	
CONCLUSIONS	
	
From	a	mechanistic	perspective	the	relationship	between	dietary	sodium	intake	and	blood	
pressure	can	be	described	as:	a)	dietary	salt	intake	is	a	key	factor	in	the	development	of	
hypertension;	b)	dietary	salt	intake	is	a	factor	only	when	considered	in	relation	to	calcium,	
magnesium,	and	potassium.		Interventional	trials	are	unlikely	to	solve	this	query	as	nutritional	
therapies	for	prevention	and/or	control	of	hypertension	operate	via	multiple	complex	and	
interactive	pathways	that	can’t	be	reduced	to	a	few	specifics.			
	
There	is	general	consensus	on	the	following:	a)	restricting	sodium	intake	in	patients	with	
hypertension	reduces	blood	pressure;	b)	a	lower	dietary	salt	intake	may	help	patients	stop	
blood	pressure	medications	while	maintaining	good	control;	c)	the	long	term	effects	of	reduced	
salt	intake	on	blood	pressure,	mortality,	and	morbidity	in	a	population	with	and	without	
hypertension	is	yet	undefined.			
	
Confounding	issues	include:		a)	few	deaths	and	cardiovascular	events	have	been	reported	
in	salt	reduction	trials;	b)	systematic	reviews	show	only	a	discrete	effect	on	blood	pressure	(1.1	
mm	Hg	systolic	and	0.6	mm	Hg	diastolic	with	sodium	reductions	of	~	25%);	c)	interventions	used	
in	clinical	trials	are	highly	intensive	and	not	suited	to	primary	care	or	prevention	programs;	d)	
data	on	the	effects	of	dietary	sodium	reduction	per	se	on	overall	health	is	sparse.		
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